Luminopia

United States
Primghar, Iowa, United States

Company profile

Luminopia company profile

Luminopia develops a new class of treatments for significant neuro-visual disorders. The company is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One, to treat amblyopia, the cause of vision loss among children.

Business identity

Contact email
[email protected]
Phone number
1 833-458-6466
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0+
Founded
2015-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$33.2M
Last funding
Series A / $16M / 2023-06-27
Last equity funding
Series A / $16M
Investors
10
Lead investors
2
Founders
4
Articles
17

Founders and investors

Founders

Alex WendlandDean TraversRaphael RouvinovScott Xiao

Lead investors

Shangbay CapitalU.S. Venture Partners

Investors

Bantam GroupMassChallengeShangbay CapitalSony Innovation FundU.S. Venture Partners